Allevyn - Ag Non-Adhesive (loose)

£34.00
Includes 48h tracked delivery
In stock
Size
 More payment options

Pickup available at Pharmacy

Usually ready in 24 hours

View store information

Indications

  • For exudate absorption and management of partial to full-thickness wounds, including:

    • Ulcers (venous, arterial, diabetic)

    • Pressure sores

    • Donor sites

    • Surgical incisions & excisions

    • Burns (1st and 2nd degree)

  • Maintains a moist wound environment → optimal for healing

  • Provides physical separation from external contaminants, helping reduce bacterial contamination


Key Features

  • Optimal exudate management

  • Wide range of dressing sizes

  • Can be left in place for up to 7 days (5 days for sacral dressings, depending on exudate levels)

  • Breathable top film

  • Foam core with non-adherent wound contact layer

  • Profiled edges for comfort and conformability

  • Waterproof and protective against leakage

  • Conformable, comfortable, and low allergy


Benefits

  • Promotes rapid wound closure with reduced maceration, leakage, and odour

  • Helps reduce bacterial load (in vitro)

  • Provides longer wear time and fewer dressing changes

  • Easy to apply, remove in one piece, available in various sizes/shapes

  • Maintains moist wound interface for optimal healing

  • Prevents trauma by minimising tissue adherence → less pain on removal

  • Cost-effective, convenient wound management


Precautions

  • External use only

  • Not compatible with oxidising agents (e.g., EUSOL), hydrogen peroxide, oil-based products (e.g., petrolatum), or some topical antimicrobials

  • Not intended for infected wounds (but may be used as adjunct under clinical protocol)

  • Not suitable for cavity wounds (may be used as a secondary cover)

  • May cause redness/irritation in fragile skin if exudate remains in contact too long

  • Avoid contact with electrodes or conductive gels (EEG/ECG)

  • May cause warming during MRI scans

  • Use caution in patients with:

    • Hepatic or renal impairment

    • G6PD deficiency

  • May alter systemic drug effects (e.g., oral hypoglycaemics, phenytoin) → monitor levels if necessary

Product Information Leaflet

Indications

  • For exudate absorption and management of partial to full-thickness wounds, including:

    • Ulcers (venous, arterial, diabetic)

    • Pressure sores

    • Donor sites

    • Surgical incisions & excisions

    • Burns (1st and 2nd degree)

  • Maintains a moist wound environment → optimal for healing

  • Provides physical separation from external contaminants, helping reduce bacterial contamination


Key Features

  • Optimal exudate management

  • Wide range of dressing sizes

  • Can be left in place for up to 7 days (5 days for sacral dressings, depending on exudate levels)

  • Breathable top film

  • Foam core with non-adherent wound contact layer

  • Profiled edges for comfort and conformability

  • Waterproof and protective against leakage

  • Conformable, comfortable, and low allergy


Benefits

  • Promotes rapid wound closure with reduced maceration, leakage, and odour

  • Helps reduce bacterial load (in vitro)

  • Provides longer wear time and fewer dressing changes

  • Easy to apply, remove in one piece, available in various sizes/shapes

  • Maintains moist wound interface for optimal healing

  • Prevents trauma by minimising tissue adherence → less pain on removal

  • Cost-effective, convenient wound management


Precautions

  • External use only

  • Not compatible with oxidising agents (e.g., EUSOL), hydrogen peroxide, oil-based products (e.g., petrolatum), or some topical antimicrobials

  • Not intended for infected wounds (but may be used as adjunct under clinical protocol)

  • Not suitable for cavity wounds (may be used as a secondary cover)

  • May cause redness/irritation in fragile skin if exudate remains in contact too long

  • Avoid contact with electrodes or conductive gels (EEG/ECG)

  • May cause warming during MRI scans

  • Use caution in patients with:

    • Hepatic or renal impairment

    • G6PD deficiency

  • May alter systemic drug effects (e.g., oral hypoglycaemics, phenytoin) → monitor levels if necessary

Product Information Leaflet